Locations
Toronto, ON, Canada
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2018
Micellae is an innovative technology-based company that has developed the O2W Self-Microemulsifying Drug Delivery System (SMEDDS), which significantly enhances the solubility and bioavailability of cannabinoids. Founded on 15 years of research at the University of Toronto, Micellae aims to provide advanced drug delivery systems for pharmaceutical and medical cannabis producers. Their proprietary product platforms, free of polyethylene glycols, offer customizable and tunable formulations that improve safety and efficacy. With a focus on sustainability and innovation, Micellae positions itself as a leader in cannabinoid delivery, backed by a team of experts in drug delivery systems and a commitment to high-quality, reliable products.
Something looks off?